Document Detail

Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.
MedLine Citation:
PMID:  15329967     Owner:  NLM     Status:  MEDLINE    
Mario Pini
Related Documents :
15586107 - Outcome data for peripherally inserted central catheters used in an acute care setting.
2610817 - Hospital and home care of sutureless percutaneous catheters.
453497 - A complication of subarachnoid phenol blockade.
2210207 - Enteroscopy and enteroclysis: an improved method for combined procedure.
10839247 - When the care giver needs care.
11568837 - Clinical facial photography in a small office: lighting equipment and technique.
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC     Volume:  26     ISSN:  1701-2163     ISO Abbreviation:  J Obstet Gynaecol Can     Publication Date:  2004 Jul 
Date Detail:
Created Date:  2004-08-26     Completed Date:  2004-10-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  101126664     Medline TA:  J Obstet Gynaecol Can     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  625; author reply 626     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contraceptives, Oral, Combined / adverse effects*
Cyproterone Acetate / administration & dosage,  adverse effects
Ethinyl Estradiol / administration & dosage,  adverse effects
Italy / epidemiology
Risk Factors
Thromboembolism / epidemiology*,  etiology
Reg. No./Substance:
0/Contraceptives, Oral, Combined; 427-51-0/Cyproterone Acetate; 57-63-6/Ethinyl Estradiol
Comment On:
J Obstet Gynaecol Can. 2003 Dec;25(12):1011-8   [PMID:  14663535 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Accelerating whole-cell biocatalysis by reducing outer membrane permeability barrier.
Next Document:  Extremely high body mass index is not a contraindication to laparoscopic gastric bypass.